Year 2016

Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors

Qian ZR1, Li T, Ter-Minassian M, Yang J, Chan JA, Brais LK, Masugi Y, Thiaglingam A, Brooks N, Nishihara R, Bonnemarie M, Masuda A, Inamura K, Kim SA, Mima K, Sukawa Y, Dou R, Lin X, Christiani DC, Schmidlin F, Fuchs CS, Mahmood U, Ogino S, Kulke MH

Pancreas. 2016 Sept

READ MORE

Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results from the First Global Survey of Patients with NETs

Singh S, Granberg D, Wolin E, Warner R, Sissons M, Kolarova T, Goldstein G, Pavel M, Oberg K, Leyden J

Journal of Global Oncology. 2016 June : 1-11

READ MORE

Somatostatin Analogues in Neuroendocrine Tumors

Kulke, MH

J Natl Compr Canc Netw. 2016 March; 14(3): 241-242

READ MORE

Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms

Modlin IM1, Bodei L2, Kidd M3.

Best Practice & Research Clinical Endocrinology & Metabolism. 2016 January; 30(1): 59-77

READ MORE

Year 2015

Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors

Khan TM1, Garg M, Warner RR, Uhr JH, Divino CM.

Pancreas. 2015 Dec [epub ahead of print]

READ MORE

Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study

Haugvik SP1,2, Janson ET3, Österlund P4, Langer SW5, Falk RS6, Labori KJ7, Vestermark LW8, Grønbæk H9, Gladhaug IP7,10, Sorbye H11

Ann Surg Oncol. 2015 Dec [epub ahead of print]

READ MORE

New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors

Phan AT, Kunz PL1, Reidy-Lagunes DL

Clin Adv Hematol Oncol. 2015 May; 13(5 Suppl 5): 1-18; quiz 1 p following 18

READ MORE

Year 2014

NCCN Clinical Practice Guidelines In Oncology, Neuroendocrine Tumors

National Comprehensive Cancer Network (NCCN). 2014 November: 1-108

READ MORE

Molecular pathology and genetics of gastrointestinal neuroendocrine tumors

Lewis MA, Yao JC

Curr Opin Endocrinol Diabetes Obes . 2014; 21(000-000): e-published ahead of print

READ MORE

Prospective of 68Ga-Radiopharmaceutical Development

Velikyan, Irina

Theranostics. 2014; 4(1): 47-80. doi: 10.7150/thno.7447

READ MORE

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

Caplin ME, Pavel M, Ruszniewski P.

N Engl J Med. 2014 July; 371(16): 224-233

READ MORE

Recommendations for management of patients with neuroendocrine liver metastases

Frilling A1, Modlin IM2, Kidd M3, Russell C4, Breitenstein S5, Salem R6, Kwekkeboom D7, Lau WY8, Klersy C9, Vilgrain V10, Davidson B4, Siegler M11, Caplin M12, Solcia E9, Schilsky R13; Working Group on Neuroendocrine Liver Metastases.

Lancet Oncol. 2014 Jan; 15(1): e8-e21

READ MORE

Year 2013

Everolimus Plus Octreotide Long-Acting Repeatable in Patients with Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

Castellano D, Bajetta E, Panneerselvam A, Saletan S, Kocha W, O’Dorisio T, Anthony LB, Hobday T

The Oncolgist. 2013; 18: 46-53

READ MORE

The Genomic Landscape of Small Intestine Neuroendocrine Tumors

Banck MS, Kanwar R, Kulkarni AA, Boora GK, Metge F, Kipp BR, Zhang L, Thorland EC, Minn KT, Tentu R, Eckloff BW, Wieben ED, Wu Y, Cunningham JM, Nagorney DM, Gilbert JA, Ames MM, Beutler AS

J Clin Invest. 2013 May 15

READ MORE

United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment.

trosberg J, Casciano R, Stern L, Parikh R, Chulikavit M, Willet J, Liu Z, Wang X, Grzegorzewski KJ

World J Gastroenterolo. 2013 April 21; 19(15): 2348-2354

READ MORE

Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options

Vicha A, Musil Z, Pacak K

Curr Opin Endocrinol Diabetes Obes. 2013 Mar 11

READ MORE

Advances in Pulmonary Neuroendocrine Tumor Management

Kjell Oberg

Advances in Pulmonary Neuroendocrine Tumor Management. 2013 March: doi: 10.2217/9781780841625 eISBN (PDF): 978-1-78084-162-5

READ MORE

Are Neuroendocrine Tumors Going Mainstream?

Kulke, M

JCO. 2013 Feb 1; 31(4): 404-405 [Epub ahead of print]

READ MORE

Practical Guidance on Peptide Receptor Radionuclide Therapy (PRRNT) for Neuroendocrine Tumours

International Atomic Energy Agency

IAEA Human Health Series. 2013

READ MORE

Year 2012

Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)

Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML

J Clin Endocrinol Metab. 2012 Jun 20; [Epub ahead of print]

READ MORE

The management of neuroendocrine tumours: current and future medical therapy options.

Oberg, KE

Clin Oncol (R Coll Radiol). 2012 May 24; 24(4): 282-93. Epub 2011 Sep 9.

READ MORE

Management of neuroendocrine tumors in children, adolescents, and young adults

Howell D, O’Dorisio MS

J Pediatr Hematol Oncol. 2012 May; 34(Supple 2): S64-68

READ MORE

The risk of metachronous cancers in patients with small intestinal carcinoid tumors: a US population-based study.

Amin S, Warner RR, Itzkowitz SH, Kim MK

Endocr Relat Cancer. 2012 Mar 27; [Epub ahead of print]

READ MORE

Year 2011

Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor Therapy.

Bousquet C, Lasfargues C, Chalabi M, Moatassim Billah S, Susini C, Vezzosi D, Caron P, Pyronnet S

J Clin Endocrinol Metab. 2011 Dec 14; [Epub ahead of print]

READ MORE

Management of Neuroendocrine Tumors of Unknown Origin

Polish A, Vergo MT, Agulnik M

J Natl Compr Canc Netw. 2011; 9(12): 1397-1403

READ MORE

Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.

Harring TR, Nguyen NT, Goss JA, O’Mahony CA

Int J Hepatol. 2011 Oct 13; 2011;2011:154541(doi: 10.4061/2011/154541)

READ MORE

Year 2010

Targeted Radionuclide Therapy for Neuroendocrine Tumours: Principles and Application

Maralyn R. Drucea Val Lewingtonb Ashley B. Grossman

Neuroendocrinology. 2010; 91(1): 1-15. Epub 2009 Jul 7.

READ MORE

New Medical Strategies for Midgut Carcinoids

Ola Nilsson1, Yvonne Arvidsson1, Viktor Johanson2, Eva Forssell-Aronsson3 and Håkan Ahlman2,*
Departments of Pathology1, Surgery2 and Radiation Physics3 at the   Sahlgrenska Academy, University of Gothenburg, Gothenburg,
Sweden

Anti-Cancer Agents in Medicinal Chemistry. 2010; 10: 250-269

READ MORE

Paraneoplastic syndromes secondary to neuroendocrine tumours

Kaltsas G, Andoulakis II, de Herder WW, Grossman, AB

Endocrine-Related Cancer. 2010 Jul 28; 17(3): R173-R193 Print 2010 Sept

READ MORE

Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors.

Gilbert JA, Adhikari LJ, Lloyd RV, Rubin J, Haluska P, Carboni JM, Gottardis MM, Ames MM

Endocr Relat Cancer. 2010 Jun 25; 17(3): 623-36. Print 2010

READ MORE

Functional Imaging of NeuroendocrineTumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET

Tina Binderup, Ulrich Knigge, Annika Loft, Jann Mortensen, Andreas Pfeifer, Birgitte Federspiel, Carsten Palnaes Hansen, Liselotte Højgaard, and Andreas Kjaer

Authors’ Affiliations: Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark; Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

J Nucl Med. 2010 May; 51: 704–712

READ MORE

Identification of a Novel Raf-1 Pathway Activator that Inhibits Gastrointestinal Carcinoid Cell Growth

Mackenzie R. Cook, Scott N. Pinchot, Renata Jaskula-Sztul, Jie Luo, Muthusamy Kunnimalaiyaan, and Herbert Chen

Authors’ Affiliations: Endocrine Surgery Research Laboratory, University of Wisconsin, and the University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

 

Mol Cancer Ther. 2010 Jan 26; 9(2): 429–37

READ MORE

Year 2009

Biochemical testing for neuroendocrine tumors

Vinik AI, Silva MP, Woltering EA, Go VL, Warner R, Caplin M.
Eastern Virginia Medical School, Strelitz Diabetes Research Center,  Norfolk, VA 23510, USA

Pancreas. 2009 Nov; 38(8): 876-89

READ MORE

Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management, Fourth Edition (PDF file, full text, 259 pages)

Gregg Mamikunian, MS; Aaron I. Vinik, MD, PhD, FCP, MACP; Thomas M. O’Dorisio, MD; Eugene A. Woltering, MD, FACS; Vay Liang W. (Bill) Go, MD

Inter Science Institute. 2009

READ MORE

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Echocardiography

Ursula Plöckingera Björn Gustafssonb Diana Ivanc Waldemar Szpakd
Joseph Davaree and all other Mallorca Consensus Conference participants

a Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany;
b Medisinsk avd Gastroseksjon, St Olavs Hospital HF, Trondheim, Norway;
c Endocrinology and Diabetology, Klinikum der Philipps-Universität, Marburg, Germany;
d Westville Hospital, Amanzimototi, Mayville, South Africa;
e Department of Cardiology, Royal Free Hospital, London, UK

Neuroendocrinology. 2009; 90: 190-193

READ MORE

Sunitinib paves the way for targeted therapies in neuroendocrine tumors

Raymond E, Faivre S, Hammel P, Ruszniewski P

Department of Medical Oncology and Gastroenterology,
Beaujon University Hospital, Clichy, France,
eric.raymond@bjn.aphp.fr

Targeted Oncology . 2009; 4: 253-254

READ MORE

Molecular target therapy for gastroenteropancreatic endocrine tumours: Biological rationale and clinical perspectives

Gabriele Capursoaa,1, Nicola Faziobb,1, Stefano Festaaa, Francesco Panzutoaa, Filippo De Braudbb, Gianfranco Delle Faveaaa,*

a Digestive and Liver Disease Unit, S. Andrea Hospital, II Medical School, University “La Sapienza”, Via Di Grottarossa 1035-1039, 00189, Rome, Italy

 b Unit of Clinical Pharmacology and New Drugs, European Institute of Oncology, Milan, Italy

Critical Reviews in Oncology/Hematology. 2009; 72: 110-124

READ MORE

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans-Helge Müller, Carmen Schade-Brittinger, Klaus-Jochen Klose, Peter Barth, Matthias Wied, Christina Mayer, Behnaz Aminossadati, Ulrich-Frank Pape, Michael Bläker, Jan Harder, Christian Arnold, Thomas Gress, and Rudolf Arnold

Journal of Clinical Oncology. 2009 Oct 1; 27(28): 4656-63

READ MORE

Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR

Toumpanakis C, Garland J, Marelli L, Srirajaskanthan R, Soh J, Davies P, Buscombe J, Caplin ME.
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK.

Alimentary Pharmacology & Therapeutics Journal. 2009 Oct; 30(7): 733-40. Epub 2009 Jul 2.

READ MORE

Pancreatic neuroendocrine tumors: presentation, management, and outcomes

Nissen NN, Kim AS, Yu R, Wolin EM, Friedman ML, Lo SK, Wachsman AM, Colquhoun SD

Am Surg. 2009 October; 75(10): 1025-9

READ MORE

Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients with Neuroendocrine Tumor

Catharina M. Korse, Babs G. Taal, Cornelis A. de Groot, Robert H. Bakker, and Johannes M.G. Bonfrer

Journal Clinical Oncology. 2009 Sep 10; 27: 4293-4299

READ MORE

Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors

Strosberg J, Nasir A, Coppola D, Wick M, Kvols L

Hum Pathol. 2009 Sep; 40(9): 1262-8. Epub 2009 Apr 14

READ MORE

Treatment of metastatic carcinoid tumors with radiolabeled biologic molecules

Bushnell D.
University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA.david-bushnell@uiowa.edu

Bushnell D. University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA. david-bushnell@uiowa.edu. 2009 Jul 7; 7(7): 760-4

READ MORE

Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome

Swärd C, Johanson V, Nieveen van Dijkum E, Jansson S, Nilsson O, Wängberg B, Ahlman H, Kölby L

British Journal of Surgery. 2009 May

READ MORE

Year 2008

NCI Carcinoid/NET Summit 2007; Main Conclusions

Irvin M. Modlin , Steven F. Moss , Daniel C. Chung , Robert T . Jensen , Elizabeth Snyderwine

J Natl Cancer Inst.. 2008 Sep 17; 100(18): 1282-1289

READ MORE

Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients

Woltering EA, Salvo VA, O’Dorisio TM, Lyons J 3rd, Li G, Zhou Y, Seward JR, Go VL, Vinik AI, Mamikunian P, Mamikunian G.

Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA. ewolte@lsuhsc.edu

Pancreas. 2008 Jul; 37(1): 94-100

READ MORE

Early and Late Results of Valvular Surgery for Carcinoid Heart Disease

Javier G. Castillo, Farzan Filsoufi, Parwis B. Rahmanian, Anelechi Anyanwu, Jerome S. Zacks, Richard R.P. Warner, David H. Adam

Journal of the American College of Cardiology. 2008 April 15; 51(15): 1507-1509

READ MORE

Bronchopulmonary Carcinoid: Phenotype and Long-term Outcome in a Single-Institution Series of Italian Patients

Massimo Rugge, Matteo Fassan, Roberto Clemente4, Giovanna Rizzardi,
Luciano Giacomelli, Gianmaria Pennelli, Claudia Mescoli1, Daniela Segat, and Federico Rea

Clinical Cancer Research. 2008 Jan 1; 14: 149-154. doi: 10.1158/1078-0432.CCR-07-1631

READ MORE

Year 2007

Population-based study of islet cell carcinoma

Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB. Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. jyao@mdanderson.org

 

Ann Surg Oncol. 2007 Dec; 14(12): 3492-500. Epub 2007 Sep 26.

READ MORE

Peptide receptor radionuclide therapy with (177) Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

van Essen M, Krenning EP, Bakker WH, de Herder WW, van Aken MO, Kwekkeboom DJ

Eur J Nucl Med Mol Imaging . 2007; 34(8): 1219-1227

READ MORE

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Ekeblad S, Eriksson B, Sundin A, Welin S, Granberg D, Kindmark H, Dunder K, Kozlovacki G, Örlefors H, Sigurd M, Öberg K, Janson ET, Skogseid B

Clin Cancer Res. 2007; 13(10): 2986-2991

READ MORE

Tumor Suppressor Role of Notch-1 Signaling in Neuroendocrine Tumors

Muthusamy Kunnimalayaan, Herbert Chen

Endocrine Surgery Research Laboratories, Department of Surgery, The University of Wisconsin, and the University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, USA

The Oncologist . 2007; 12: 535–542

READ MORE

Response of atypical pulmonary carcinid tumors to chemotherapy. A retrospective study of 37 patients

Guigay J.
Poster presented at the12th World Conference on Lung Cancer, Seoul, Korea, September 2007.

 

READ MORE

Valproic Acid Activates Notch-1 Signaling and Regulates the Neuroendocrine Phenotype in Carcinoid Cancer Cells

Greenblatt DY, Vaccaro AM, Jaskula-Sztul R, Ning L, Haymart M, Kunnimalaiyaan M, Chen H

 

F.A.C.S., H4/750 Clinical Science Center, 600 Highland Avenue, Madison, Wisconsin 53792, USA.

Oncologist. 2007 Aug; 12(8): 942-51

READ MORE

Chemoembolization and Bland Embolization of Neuroendocrine Tumor Metastases to the Liver (Full text)

Ruutiainen AT, Soulen MC, Tuite CM, Clark TW, Mondschein JI, Stavropoulos SW, Trerotola SO.

Division of Interventional Radiology, University of Pennsylvania, 1 Silverstein, Philadelphia, PA 19104, USA

J Vasc Interv Radiol. 2007 Jul; 18(7): 847-55

READ MORE

Year 2006

Over expression of the Notch1 intracellular domain (NICD) inhibits cellular proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells

Muthusamy Kunnimalaiyaan, Abram M. Vaccaro, Mary A. Ndiaye, and Herbert Chen

J. Biol. Chem. 2006 Nov 7: 10.1074/jbc.M603578200

READ MORE

ENETS 2007 Consensus Guidelines for the Management pf Patients with Digestive Neuroendocrine tumors. Part1 Stomach, Duodenum and Pancreas

Wouter De Herder, Dermot O’Toole, Guido Rindi, Bertram Wiedenmann

Karger Neuro endocrinology . 2006; 84(3): 151-153

READ MORE

Diagnosis and Management of Neuroendocrine Tumors

by Rudolph Arnold, M.D., FRCP
8th United European Gastroenterology Week

READ MORE

Liver metastases of neuroendocrine tumors; early reduction of tumour load lead to improved life expectancy (full text)

Liesbeth M Veenendaal1, Inne HM Borel Rinkes1, Cornelis JM Lips2and Richard van Hillegersberg*1, Netherlands.

World Journal of Surgical Oncology. 2006 Jun 26; 4: 35

READ MORE

Therapeutic Options for Gastrointestinal Carcinoids (Abstract)

Irvin M. Modlin, Igor Latich, Mark Kidd, Michelle Zikusoka, and Geeta Eick

 

Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062, USA. imodlin@optonline.net

 

Clin Gastroenterol Hepatol. 2006 May; 4(5): 526-47

READ MORE

Surgery for Gastrinoma and Insulinoma in MEN 1 (Abstract)

Norton JA, Fang TD, Jensen RT

J Natl Compr Canc Netw. 2006 Feb; 4(2): 148-53

READ MORE

Year 2005

Goblet cell carcinoid of the appendix

Payam S Pahlavan1  and Rani Kanthan2

1Department of Physiology and Pathophysiology, University of  Heidelberg, Heidelberg, Germany

2Department of Pathology, University of Saskatchewan, Saskatoon, Canada

World Journal of Surgical Oncology. 2005; 3: 36

READ MORE

Biochemical assessment of niacin deficiency among carcinoid cancer patients.

Shah GM, Shah RG, Veillette H, Kirkland JB, Pasieka JL, Warner RR

Am J Gastroenterol. 2005 Oct; 100(10): 2307-14

READ MORE

Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors

Wang GG, Yao JC, Worah S, White JA, Luna R, Wu TT, Hamilton SR, Rashid A

Mod Pathol. 2005 Aug; 18(8): 1079-87

READ MORE

Enteroendocrine Tumors Other Than Carcinoid: A Review of Clinically Significant Advances

Richard R.P. Warner
Gastrointestinal Division, Department of Medicine
The Mount Sinai School of Medicine, New York, NY

Gastroenterology. 2005 May : 1668-1684

READ MORE

Current Status of Gastrointestinal Carcinoids

Irvin M. Modlin, Mark Kidd, Igor Latich, Michelle N. Zikusoka, and Michael D. Shapiro

 

Gastric Pathobiology Research Group, GI Surgical Division, Yale University School of Medicine, New Haven, Connecticut Revie

Gastroenterology. 2005 May; 128: 1717-1751

READ MORE

A Discussion on the Utility of Various Routes of Administration of Octreotide Acetate

Eugene A. Woltering MD FACS
The James D. Rives Professor of Surgery and Neurosciences
Louisiana State University Health Sciences Center
New Orleans LA 70065

READ MORE

Carcinoid tumor of the appendix in childhood: the experience of two Italian institutions

Dall’Igna P, Ferrari A, Luzzatto C, Bisogno G, Casanova M, Alaggio R, Terenziani M, Cecchetto G

J Pediatr Gastroenterol Nutr. 2005 Feb; 40(2): 216-9

READ MORE

Metastatic Carcinoid Tumors: A Clinical Review

Johann M. Zeutenhorst, Babs G. Taal

Oncologist. 2005 Feb; 10(2): 123-31

READ MORE

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, O’dorisio TM, Valkema R, Bodei L, Chinol M, Maecke HR, Krenning EP

J Nucl Med. 2005 Jan; 46(1): 62S-6S

READ MORE

Year 2004

Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy

Wirth LJ, Carter MR, Jänne PA, Johnson BE

Lung Cancer. 2004; 44: 213-20

READ MORE

Considerations Concerning a Tailored, Individualized Therapeutic Management of Patients with (neuro)Endocrine Tumors of the Gastrointestinal Tract and Pancreas

W W de Herder, E P Krenning, C H J van Eijck 2 and S W J Lamberts

Endocrine-Related Cancer . 2004; 11: 19-34

READ MORE

Carcinoid heart disease : presentation, diagnosis, and management

Fox DJ, Khattar RS

Heart. 2004 Oct; 90(10): 1224-8

READ MORE

Updated Population-Based Review of Carcinoid Tumors

By Maggard MA, O’Connell JB, Ko CY.

Anna Surg. 2004 Jul; 240(1): 117-22

READ MORE

Gastroenteropancreatic Neuroendocrine Tumor Disease: Molecular and Cell Biological Aspects

Edited by Bertram Wiedenmann; Gerhard M. Christofori; Michael Hoecker

 

 

Annals of the New York Academy of Sciences . 2004 April; 1014

READ MORE

Current Status of the Diagnosis and Treatment of Hereditary and Sporadic Neuroendocrine Tumors of the Gastroenteropancreatic System

European Neuroendocrine Tumor Society (ENETS), Budapest, March 2004
Neuroendocrinology 80 (suppl) 1 1-140(2004)
Editor B Wiedenmann, Publisher Karger
Access Author and Subject Index
Order information
Pictures from the Budapest conference

Neuroendocrinology . 2004 Mar; 80(1)

READ MORE

Year 2003

Carcinoid Heart Disease

By Zuetenhorst JM, Taal BG.

N Engl J Med. 2003 Jun 5; 348(23): 2359-61

READ MORE

Additional references regarding treatment of patients with bronchial carcinoids

Provided by
Dan Granberg, MD, PhD, Consultant, Assistant Head of Department
Department of Endocrine Oncology
University Hospital
SE-751 85 Uppsala
Sweden

READ MORE

A 5-Decade Analysis of 13,715 Carcinoid Tumors

By Irving M. Modlin, M.D., Kevin D. Lys, M.D., Mark Kidd, Ph.D.

Cancer. 2003 Feb 15; 97(4): 934-59

READ MORE

Year 2002

A Carcinoid Tumor Associated with Chylous Ascites and Elevated Tumor Markers

Warner RR, Croen EC, Zaveri K, Ratner L

Int J Colorectal Dis. 2002 May; 17(3): 156-60

READ MORE

Carcinoid Tumors: Molecular genetics, tumor biology, and update of diagnosis and treatment

Article by Oberg Kjell M.D.
Department of Medical Sciences, Uppsala University Hospital,
Uppsala, Sweden.

Current Opinion Oncology. 2002 Jan; 14(1): 38-45

READ MORE

Year 2001

Experience in treatment of metastatic pulmonary carcinoid tumors

Granberg D, Eriksson B, Wilander E, Grimfjärd P, Fjällskog M-L, Öberg K, Skogseid B. Experience in treatment of metastatic pulmonary carcinoid tumors.

Ann Oncol. 2001; 12(10): 1383-1391

READ MORE

Lung and thymic neuroendocrine tumors

Granberg D, Skogseid B

Doherty G, Skogseid B, eds. Surgical Endocrinology. Philadelphia. Lippincott Williams & Wilkins.. 2001: 413-430

READ MORE

Bronchial Carcinoid

By Dan Granberg M.D. : Bronchial Carcinoids.

Uppsala. 2001: 75p

READ MORE

Year 2000

Miscellaneous